Sugi Predict

Sugi Predict / Compounds / SCHEMBL6729254

SCHEMBL6729254

SCHEMBL6729254

N#Cc1cccc(-n2c(-c3cc(F)c(S(N)(=O)=O)c(F)c3)csc2=O)c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.37
▸ CA2 P00918 3/20 0.37
▸ CA12 O43570 2/20 0.37
▸ CA9 Q16790 2/20 0.37
▸ NOTUM Q6P988 1/20 0.34
▸ TDP2 O95551 1/20 0.34
▸ NSD2 O96028 1/20 0.33
▸ FADS1 O60427 3/20 0.33
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ PTGS1 P23219 2/20 0.32
▸ PTGS2 P35354 2/20 0.32
▸ CTSG P08311 1/20 0.32
▸ CMA1 P23946 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6730267 0.88 CA12 (0.37) CA1CA2CA12CA9NOTUM
SCHEMBL6735390 0.88 PTGS2 (0.38) CA1CA2CA12CA9PTGES2
SCHEMBL6737335 0.85 CA1 (0.36) CA1CA2CA12CA9PTGS1
SCHEMBL6728919 0.84 PTGS2 (0.43) CA1CA2CA12CA9PTGES2
SCHEMBL6740773 0.84 CA1 (0.39) CA1CA2CA12CA9PTGS1
SCHEMBL6723318 0.82 PTGS2 (0.39) NOTUMNSD2FADS1ALOX5PTGS1
SCHEMBL6729121 0.82 GAA (0.38) CA1CA2CA12CA9PTGES2
SCHEMBL6731572 0.82 PTGS2 (0.51) PTGS1PTGS2
SCHEMBL6739556 0.81 CA1 (0.36) CA1CA2CA12CA9NOTUM
SCHEMBL6739274 0.81 AR (0.36) PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 — — US claimed
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-07-15 — — US disclosed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 — — US disclosed
US-6673818-B2 TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS ARTHRITIS, PAIN, FEVER AND CANCER PHARMACIA CORPORATION 2004-01-06 — — US disclosed
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-08-07 — — US disclosed
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-02-13 — — US disclosed
EP-1251126-A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation Pharmacia Corporation (US) 2002-10-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 CA1 2085/4885CA2 3175/4885CA12 4391/4885
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 CA1 2085/4885CA2 3175/4885CA12 4391/4885
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 CA1 2085/4885CA2 3175/4885CA12 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.